ArticleTranslational andrology and urology2022

Real-world data on the efficacy and safety of pazopanib in IMDC favorable- and intermediate-risk metastatic renal cell carcinoma: a multicenter retrospective cohort study of Chinese patients.

Aihetaimujiang Anwaier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.